Table 2

Bacteria detected and susceptibility profile
Isolates n (%) Trimethoprim Fosfomycin Nitrofurantoin Ciprofloxacin
S n (%) I n (%) R n (%) S n (%) I n (%) R n (%) S n (%) I n (%) R n (%) S n (%) I n (%) R n (%)
All 191 (100)
E. coli 139 (72.7) 105 (80.8) 2 (1.7) 23 (17.5) 126 (95.5) 0 (0) 6 (4.5) 130 (94.2) 5 (3.6) 3 (2.2) 126 (91.3) 0 (0) 12 (8.7)
Other typical uropathogens 71 (37.2) 28 (50) 0 28 (50) 46 (76,8) 1 (1.7) 13 (21.7) 43 (68.2) 5 (7.9) 15 (23.8) 48 (77.4) 9 (14.5) 5 (8.1)
Enterococcus faecalis 26 (13.6) 6 0 14 15 1 6 21 0 2 16 5 2
Proteus mirabilis 11 (5.7) 1 0 8 8 0 0 0 0 10 9 0 0
Staph. saprophyticus 4 (2.1) 4 0 0 3 0 1 4 0 0 4 0 0
Staph. others 5 (2.6) 1 0 2 3 0 0 1 2 0 2 1 0
Strept. agalacticae 8 (4.2) 2 0 3 7 0 0 7 0 0 2 3 2
Kleb pneumoniae 14 (7.3) 12 0 1 10 0 4 9 2 3 13 0 1
Staph. aureus 3 (1.6) 2 0 0 0 0 2 1 1 0 2 0 0

In the first column typical uropathogens and the number of isolates are documented. In the upper two rows results of susceptibility testing against E. coli and all other typical uropathogens are presented. Due to the low numbers no percent rates are given in the remaining rows.

Schmiemann et al.

Schmiemann et al. BMC Urology 2012 12:33   doi:10.1186/1471-2490-12-33

Open Data